CBG vs CBN vs CBD vs CBC: Which Is Best for Pain?

"Is CBG or CBN better for pain? What about CBD, CBC, or plain THC?" If you've stood in front of a dispensary shelf trying to decode those letters, you've probably noticed that every product seems to promise relief. The research is more specific, and more honest, than the labels.

That short answer hides a lot of nuance. Pain isn't one thing, cannabinoids don't all act on the same receptors, and "promising in mice" is a very different statement from "works in people." Let's walk through what the research actually shows, comparison by comparison. This article also brings in the material from our earlier guide to the pain-relieving potential of cannabis.

Which cannabinoid is best for pain? What human studies show

Chronic pain is common. A CDC analysis estimated that about 21% of U.S. adults lived with chronic pain in 2021. Standard treatments help many people but carry trade-offs: the CDC's 2022 opioid prescribing guideline describes the risks of long-term opioid use, and long-term NSAID use carries gastrointestinal and kidney risks. That's the context in which so many people ask about cannabis.

The biological rationale is real. The endocannabinoid system, a network of receptors (CB1 and CB2), signaling molecules, and enzymes, is involved in pain processing at nearly every level, from peripheral nerves to the spinal cord and brain. CB1 receptors are concentrated in the nervous system; CB2 receptors are more common on immune cells.

The clinical evidence is more measured. In its 2017 report, the National Academies of Sciences concluded there was substantial evidence that cannabis or cannabinoids are effective for chronic pain in adults. Later analyses sized that benefit. A 2021 BMJ meta-analysis of randomized trials found small improvements in pain, sleep, and physical function with medical cannabis compared with placebo. A Cochrane review of neuropathic pain found that cannabis-based medicines helped somewhat more people achieve meaningful relief than placebo, with more side effects such as drowsiness and dizziness. Almost all of these trials tested THC, synthetic THC, or THC combined with CBD.

So the honest summary is this: products containing THC have the most human data, and the effect for most people is modest rather than dramatic. Responses vary a great deal from person to person.

CBG vs CBN for pain

These two are often compared because both are "minor" cannabinoids, but they behave quite differently.

CBG (cannabigerol) is non-intoxicating at typical doses. Pharmacologically it's unusual: a 2010 study found it acts strongly on alpha-2 adrenergic receptors (a target of some pain and blood-pressure medications) and blocks 5-HT1A serotonin receptors, while receptor research shows it interacts with CB1 and CB2 only weakly. In mice, CBG reduced pain sensitivity caused by chemotherapy-induced nerve damage. In people, the evidence is limited to surveys: in a 2021 survey of CBG-predominant cannabis users, most respondents reported that it worked better than their conventional medications for conditions including chronic pain. Surveys like this can't separate a real effect from expectation, and the authors called for randomized trials. A 2021 pharmacology review reaches the same conclusion: a strong case for study, not yet a proven treatment.

CBN (cannabinol) forms as THC ages. It's mildly psychoactive and is better known for sleep than for pain. In rats, CBN, CBD, and their combination reduced muscle pain sensitivity when injected locally. In people, the most rigorous CBN study we know of is a 2023 placebo-controlled sleep trial, which found that 20mg of CBN reduced nighttime awakenings; it didn't measure pain.

The comparison: neither has been shown to relieve pain in human trials. If pain keeps you awake, CBN's sleep data may be more relevant to you. If you want daytime function without intoxication, CBG is the more common choice.

CBC vs CBG, and CBC vs THC

CBC (cannabichromene) is non-intoxicating and acts on TRP channels, the same family of receptors that respond to heat and capsaicin. In anesthetized rats, CBC and CBD activated the brain's descending pain-control pathway. In human immune cells grown in the lab, CBC, THCV, and CBN reduced inflammatory signaling. A 2024 review of CBC describes the same picture: interesting mechanisms, almost no clinical data.

CBC vs CBG: both are non-intoxicating, both show anti-inflammatory activity in preclinical research, and neither has completed a human pain trial. CBG has slightly more human data overall (including a small trial on anxiety and stress, discussed below), and it's far easier to find in products.

CBC vs THC: THC has decades of clinical trials behind it; CBC has very few. The trade-off is intoxication. THC's benefit comes with its psychoactive effects, while CBC doesn't produce a high.

CBG vs CBD, CBN vs CBD, and THC vs CBG

CBD is the most studied non-intoxicating cannabinoid, and it's the one with the most surprising pain results. A 2024 systematic review found strong preclinical signals but inconsistent clinical findings. In one of the best-controlled trials, CBD taken for 12 weeks by people with hand osteoarthritis or psoriatic arthritis did no better than placebo for pain, sleep, or mood. That doesn't mean CBD has no role; it means CBD on its own, at those doses, didn't relieve this kind of pain.

CBG vs CBD: both are non-intoxicating, but they work on different targets. CBG's alpha-2 activity is distinctive. In a 2024 placebo-controlled trial, 20mg of CBG reduced anxiety and stress in healthy adults without impairment; pain wasn't measured. Many people choose CBG for daytime use and CBD as a companion to THC.

CBN vs CBD: CBN is mildly intoxicating and more often used at night; CBD is non-intoxicating. In the rat muscle-pain study above, the combination worked better than either alone, but that hasn't been tested in people.

THC vs CBG: THC is the more effective pain reliever in the current evidence and the only one of the two with substantial human data. CBG may appeal to people who can't or don't want to feel intoxicated. Some people combine them, which we explore in THC, CBD and CBG together.

THCV vs CBD

THCV (tetrahydrocannabivarin) is a close chemical relative of THC that behaves differently at low doses, partly blocking CB1 rather than activating it. In mice, THCV reduced signs of inflammation and inflammatory pain, and most current interest in THCV centers on appetite and metabolic health rather than pain.

THCV vs CBD: CBD has far more human research, though its pain results are mixed. THCV has almost none in pain. THCV also appears in very few products, and its effects at higher doses are less well characterized.

Practical considerations before using cannabinoids for pain

Older adults. Older adults are a growing share of medical cannabis users, and they may be more sensitive to dizziness, sedation, and falls. Lower starting doses and slower increases are especially sensible here.

Pregnancy and breastfeeding. The National Academies found an association between prenatal cannabis smoking and lower birth weight, and most clinical bodies advise avoiding cannabis during pregnancy and breastfeeding.

Medications. Cannabinoids, particularly CBD, are processed by the same liver enzymes as many common drugs and can change their levels. That includes some blood thinners, seizure medications, and sedatives.

Starting low. A 2021 international clinician consensus on cannabis for chronic pain suggested starting with CBD-predominant products or very low THC doses and increasing slowly. A clinician can help you decide what fits; our guide on how to talk to your doctor about cannabis can help with that conversation.

The bottom line

It's tempting to look for a winner among the cannabinoids. The research suggests a more useful question: which compounds have been tested in people with pain like yours? Today that list is short, and it mostly includes THC, with or without CBD. The minor cannabinoids are some of the most interesting science in the field, and the next decade of trials will tell us how much of their promise holds up. For more on CBG specifically, see our complete guide to CBG. Emerald Bay's White CBG tablets are a 25mg, full-spectrum option for people who want to explore CBG without intoxication.

Frequently asked questions

What is the best cannabinoid for pain?

Based on human trials, THC (often combined with CBD) has the strongest evidence, although the average benefit is modest. CBG, CBN, CBC, and THCV haven't been tested well enough in people with pain to say how they compare.

Is CBG or CBN better for pain?

Neither has been proven to relieve pain in human trials. CBG is non-intoxicating and has shown pain-reducing effects in animal studies; CBN has a small trial suggesting it may reduce nighttime awakenings. The better fit depends on whether your priority is daytime function or sleep.

Is CBG or CBD better for pain?

Neither has strong human evidence for pain on its own. CBD has more trials, and several of the best-controlled ones found no benefit over placebo. CBG has promising preclinical data and patient surveys but no completed pain trials.

What is the difference between CBC and CBG?

Both are non-intoxicating minor cannabinoids. CBG acts on alpha-2 adrenergic and serotonin receptors and weakly on cannabinoid receptors; CBC acts mainly on TRP channels. Both show anti-inflammatory effects in lab studies, and neither has been tested in human pain trials.